CG
Caroline Gaynor
OtherActivePrinciipal at Lightstone Ventures
27
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Caroline Gaynor.
Investment Thesis & Strategy
Lightstone Ventures invests in various stages of biotech, medical device, and pharmaceutical companies, seeking innovative solutions with the potential for significant impact.
Investment Activity
Deals per year over the last 5 years
3
20163
20172
20182
20191
2020Portfolio Companies
Selected investments from their portfolio of 27 companies
F
FIRE1
Other · Seed, 0
C
Catamaran Bio
Biotech · Series A, 2020
A
Atsena Therapeutics
Biotech · Series A, 2019
N
Nimbus Apollo
Biotech · Seed, 2019
T
Tallac Therapeutics
Biotech · Series A, 2018
M
Medisix Therapeutics
Biotech · Seed, 2018
P
ProVerum Medical
Healthcare · Seed, 2017
L
Locanabio
Biotech · Series A, 2017
D
Disarm Therapeutics
Biotech · Series A, 2017
T
Tizona Therapeutics
Biotech · Series A, 2016
C
Cyteir Therapeutics
Biotech · Series A, 2016
B
Bold Penguin
Fintech · Series B, 2016
Frequently Asked Questions
Caroline Gaynor focuses on Seed stage investments.